TY - JOUR T1 - Numbers of close contacts of individuals infected with SARS-CoV-2 and their association with government intervention strategies JF - medRxiv DO - 10.1101/2021.01.20.21250109 SP - 2021.01.20.21250109 AU - Conor G. McAloon AU - Patrick Wall AU - Francis Butler AU - Mary Codd AU - Eamonn Gormley AU - Cathal Walsh AU - Jim Duggan AU - T. Brendan Murphy AU - Philip Nolan AU - Breda Smyth AU - Katie O’Brien AU - Conor Teljeur AU - Martin J. Green AU - Luke O’Grady AU - Kieran Culhane AU - Claire Buckley AU - Ciara Carroll AU - Sarah Doyle AU - Jennifer Martin AU - Simon J. More Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/01/25/2021.01.20.21250109.abstract N2 - Background Contact tracing is conducted with the primary purpose of interrupting transmission from individuals who are likely to be infectious to others. Secondary analyses of data on the numbers of close contacts of confirmed cases could also: provide an early signal of increases in contact patterns that might precede larger than expected case numbers; evaluate the impact of government interventions on the number of contacts of confirmed cases; or provide data information on contact rates between age cohorts for the purpose of epidemiological modelling.Methods We analysed data from 140,204 contacts of 39861 cases in Ireland from 1st May to 1st December 2020. Only ‘close’ contacts were included in the analysis. A close contact was defined as any individual who had had > 15 minutes face-to-face (<2 m) contact with a case; any household contact; or any individual sharing a closed space for longer than 2 hours, in any setting.Results The number of contacts per case was overdispersed, the mean varied considerably over time, and was temporally associated with government interventions. Negative binomial regression models highlighted greater numbers of contacts within specific population demographics, after correcting for temporal associations. Separate segmented regression models of the number of cases over time and the average number of contacts per case indicated that a breakpoint indicating a rapid decrease in the number of contacts per case in October 2020 preceded a breakpoint indicating a reduction in the number of cases by 11 days.Discussion These data were collected for a specific purpose and therefore any inferences must be made with caution. The data are representative of contact rates of cases, and not of the overall population. However, the data may be a more accurate indicator of the likely degree of onward transmission than might be the case if a random sample of the population were taken. Furthermore, since we analysed only the number of close contacts, the total number of contacts per case would have been higher. Nevertheless, this analysis provides useful information for monitoring the impact of government interventions on the number of contacts; for helping pre-empt increases or decreases in case numbers, and for triangulating assumptions regarding the contact mixing rates between different age cohorts for epidemiological modelling.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo specific external funding was received for this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by both the National Research Ethics Committee (20-NREC-COV-099) and the Health Research Consent Declaration Committee (20-025-AF1/COV)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData for this study are not made publicly available ER -